L'Air Liquide S.A. (AIQUF)

Revance Therapeutics Revenue

L'Air Liquide had revenue of 13.72B EUR in the half year ending June 30, 2025, a decrease of -1.85%. This brings the company's revenue in the last twelve months to 27.40B, up 1.46% year-over-year. In the year 2024, L'Air Liquide had annual revenue of 27.06B, down -1.99%.

• Revenue (ttm): 27.40B EUR
• Revenue Growth: +1.46%
• P/S Ratio: 3.58
• Revenue / Employee: 427.32K EUR
• Employees: 64,124
• Market Cap: 115.27B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	27.06B	-549.80M	-1.99%
Dec 31, 2023	27.61B	-2.33B	-7.77%
Dec 31, 2022	29.93B	6.60B	28.28%
Dec 31, 2021	23.33B	2.85B	13.91%
Dec 31, 2020	20.49B	-1.43B	-6.55%